Re: 'Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness' by Wolkewitz et al
- PMID: 33964408
- PMCID: PMC8099537
- DOI: 10.1016/j.cmi.2021.04.026
Re: 'Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness' by Wolkewitz et al
Comment in
-
'Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness' - Author's reply.Clin Microbiol Infect. 2021 Jul;27(7):1045. doi: 10.1016/j.cmi.2021.05.019. Epub 2021 May 15. Clin Microbiol Infect. 2021. PMID: 34004265 Free PMC article. No abstract available.
Comment on
-
Methodological evaluation of bias in observational coronavirus disease 2019 studies on drug effectiveness.Clin Microbiol Infect. 2021 Jul;27(7):949-957. doi: 10.1016/j.cmi.2021.03.003. Epub 2021 Apr 1. Clin Microbiol Infect. 2021. PMID: 33813117 Free PMC article.
References
-
- Geskus R.B. 1st ed. Editor Chapman and Hall/CRC; 2015. Data analysis with competing risks and intermediate states.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical